糖尿病受者肾移植后 1 年葡萄糖代谢变化:一项多中心前瞻性 1 年研究。
Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study.
机构信息
Department of Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.
Department of Transplantation Surgery and Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.
出版信息
Front Endocrinol (Lausanne). 2023 Jun 21;14:1197475. doi: 10.3389/fendo.2023.1197475. eCollection 2023.
BACKGROUND
Diabetes mellitus is a common and crucial metabolic complication in kidney transplantation. It is necessary to analyze the course of glucose metabolism in patients who already have diabetes after receiving a transplant. In this study, we investigated the changes in glucose metabolism after transplantation, and a detailed analysis was performed on some patients whose glycemic status improved.
METHODS
The multicenter prospective cohort study was conducted between 1 April 2016 and 31 September 2018. Adult patients (aged 20 to 65 years) who received kidney allografts from living or deceased donors were included. Seventy-four subjects with pre-transplant diabetes were followed up for 1 year after kidney transplantation. Diabetes remission was defined as the results of the oral glucose tolerance test performed one year after transplantation and the presence or absence of diabetes medications. After 1-year post-transplant, 74 recipients were divided into the persistent diabetes group (n = 58) and the remission group (n = 16). Multivariable logistic regression was performed to identify clinical factors associated with diabetes remission.
RESULTS
Of 74 recipients, 16 (21.6%) showed diabetes remission after 1-year post-transplant. The homeostatic model assessment for insulin resistance numerically increased in both groups throughout the first year after transplantation and significantly increased in the persistent diabetes group. The insulinogenic index (IGI) value significantly increased only in the remission group, and the IGI value remained low in the persistent diabetes group. In univariate analysis, younger age, newly diagnosed diabetes before transplantation, low baseline hemoglobin A1c, and high baseline IGI were significantly associated with remission of diabetes. After multivariate analysis, only newly diagnosed diabetes before transplantation and IGI at baseline were associated with remission of diabetes (34.00 [1.192-969.84], = 0.039, and 17.625 [1.412-220.001], = 0.026, respectively).
CONCLUSION
In conclusion, some kidney recipients with pre-transplant diabetes have diabetes remission 1 year after transplantation. Our prospective study revealed that preserved insulin secretory function and newly diagnosed diabetes at the time of kidney transplantation were favorable factors for which glucose metabolism did not worsen or improve 1 year after kidney transplantation.
背景
糖尿病是肾移植后常见且至关重要的代谢并发症。有必要分析那些已经患有糖尿病的患者在接受移植后的葡萄糖代谢过程。本研究调查了移植后葡萄糖代谢的变化,并对一些血糖状态改善的患者进行了详细分析。
方法
多中心前瞻性队列研究于 2016 年 4 月 1 日至 2018 年 9 月 31 日进行。纳入接受活体或已故供者肾移植的成年患者(年龄 20 至 65 岁)。74 例移植前糖尿病患者在肾移植后 1 年进行随访。糖尿病缓解定义为移植后 1 年口服葡萄糖耐量试验的结果和是否存在糖尿病药物。移植后 1 年时,74 例受者分为持续糖尿病组(n = 58)和缓解组(n = 16)。采用多变量逻辑回归分析与糖尿病缓解相关的临床因素。
结果
74 例受者中,16 例(21.6%)在移植后 1 年时出现糖尿病缓解。两组患者在移植后第 1 年的稳态模型评估胰岛素抵抗均呈数值增加,且持续糖尿病组显著增加。仅缓解组的胰岛素生成指数(IGI)值显著增加,而持续糖尿病组的 IGI 值仍较低。单因素分析显示,年龄较小、移植前新发糖尿病、较低的基线糖化血红蛋白(HbA1c)和较高的基线 IGI 与糖尿病缓解显著相关。多因素分析后,仅移植前新发糖尿病和基线时的 IGI 与糖尿病缓解相关(34.00[1.192-969.84],P = 0.039 和 17.625[1.412-220.001],P = 0.026)。
结论
总之,一些移植前患有糖尿病的肾移植受者在移植后 1 年时出现糖尿病缓解。本前瞻性研究表明,在移植时保留的胰岛素分泌功能和新发糖尿病是有利因素,这些因素可使移植后 1 年的葡萄糖代谢不会恶化或改善。
相似文献
Front Endocrinol (Lausanne). 2023
Transplant Proc. 2013-5
Exp Clin Transplant. 2013-12
Can J Kidney Health Dis. 2023-4-18
Diabetes Res Clin Pract. 2021-2
引用本文的文献
Front Med (Lausanne). 2025-3-20
本文引用的文献
Adv Chronic Kidney Dis. 2021-11
Diabetes Care. 2018-1
Cochrane Database Syst Rev. 2016-8-22